CurveBeam AI Limited (ASX:CVB)

Market Cap	14.59M -64.6%
Revenue (ttm)	8.67M -28.4%
Net Income	-18.83M
EPS	-0.04
Shares Out	768.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	270,000
Open	0.0200
Previous Close	0.0190
Day's Range	0.0190 - 0.0200
52-Week Range	0.0160 - 0.1300
Beta	1.72
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeV...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 50
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CVB

Financial Performance

In fiscal year 2026, CurveBeam AI's revenue was 8.67 million, a decrease of -28.36% compared to the previous year's 12.10 million. Losses were -18.83 million, 11.8% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 27, 2026

Data Sources Report a data error